ALIBABA HLTH INFO.T.HD-01
ALIBABA HLTH INFO.T.HD-01/ BMG0171K1018 /
TWY
|
20.05.2024 22:58:03
|
Zm.
+0,008
|
Wolumen |
Bid22:58:03 |
Ask22:58:03 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
|
0,391EUR
|
+2,09%
|
-
Obrót: - |
0,391Wolumen Bid: - |
0,401Wolumen Ask: - |
5,44 mldEUR |
- |
- |
Opis działalności
Alibaba Health Information Technology Limited engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
Zarząd & Rada nadzorcza
| CEO |
| Zhu Shunyan |
| Zarząd |
| Tu Yanwu, Shen Difan, Zhang Hua, Yin Rui, Deng Yan |
| Rada nadzorcza |
| Zhu Shunyan, Shen Difan, Tu Yanwu, Huang Jiaojiao, Dr. Shao Rong, Wu May Yihong, Huang Yi Fei, (Vanessa), Xu Haipeng |
Dane firmy
| Nazwa: |
Alibaba Health Information Technology Ltd |
| Adres: |
Tower One, 26th Floor Times Square 1 Matheson Street,Causeway Bay, Hong Kong |
| Telefon: |
+86-852-2215-5100 |
| Fax: |
+86-852-2215-5200 |
| E-mail: |
alihealth_info@alibaba-inc.com
|
| Internet: |
https://www.alihealth.cn/ |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Przemysł Farmaceutyczny |
| Podsektor: |
Przemysł Farmaceutyczny |
| Koniec roku finansowego: |
31.03 |
| Free float: |
- |
| Data IPO: |
06.07.1972 |
